StockData
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc. (SANA) stock

SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.85−0.03 (-1.60%)

Close on Nov 18, 2026Market cap $553.82MP/E –Yield –

Sana Biotechnology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Sana Biotechnology's price to book ratio was 4.4× on Nov 11, 2026, against 5.8× a year earlier. Over the last 5 years it ranged from 1.2× to 9.3×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.4×−1.0
2025Dec 31, 20255.5×+4.2
2024Dec 31, 20241.2×−1.0
2023Dec 29, 20232.2×+0.9
2022Dec 30, 20221.3×−2.1
2021Dec 31, 20213.4×–

More Sana Biotechnology figures

See a number that looks wrong?